by p300 can stimulate its ability to bind to a short oligonucleotides containing a binding site from the p21 proThe p53 tumor suppressor protein is a sequence-specific transcription factor that responds to a wide variety moter, it has no effect on the ability of p53 to bind its sites within the p21 promoter when they are present in of stress signals in order to regulate processes such as cell cycle, cell death, and DNA repair. When p53 protein a much longer DNA molecule. Moreover, these authors also showed that a p53 protein deleted of its C terminus becomes stabilized (as a result of release from its negative regulator Mdm2), a number of genes are either inis actually less effective in interacting with the p21 promoter when present in either naked or chromatinized duced or repressed. P53 is extensively phosphorylated and it is likely that phosphorylation plays multiple roles DNA. Espinosa and Emerson, using a somewhat more physiological assay, have thus not only challenged the in regulating its functions. Nevertheless, phosphorylation is not the only mode by which p53 can be modified.
ences in the details of these transfections and those of Nakamura et al. (e.g., Barlev et al. used different mutants, most frequently one containing lys to arg changes at 320, the P/CAF site, as well as 373, 381, and 382), but it is not clear if these can explain the difference in results. Barlev et al. also provided evidence, in the form of ChIP assays and GST pull-downs, that p53 acetylation is required first for efficient recruitment in vivo of CBP and the PCAF complex to promoter regions and second for interaction of p53 with these factors in vitro. These findings, at least with CBP, are particularly hard to reconcile with the in vitro functional assays of Espinosa and It should be noted as well that if p53 acetylation is required for its function in transactivation, it is not sufficient since Gottifredi et al. (2001) showed that when and a mutant derivative containing lysines 370, 372, 373, DNA replication is blocked, acetylated p53 accumulates 380, and 382 changed to arg (which, as predicted, could but is transcriptionally inert. not be acetylated by p300) displayed identical levels of So while it is now quite apparent that acetylation is not activation. Suggesting a possible mechanism for this required for DNA binding by p53, different experimental activation, ChIP experiments revealed extensive p53 approaches have provided contradictory conclusions and p300-dependent histone acetylation spanning the as to whether this modification is necessary for tranp21 promoter (see Figure 2) . scriptional activation by p53. How can these differing The above studies seem to make a strong case for results be reconciled? The best current guess is that the conclusion that p53 acetylation does not play a dip53 acetylation might modestly enhance transcriptional rect role in the protein's ability to function as a transcripactivation, and perhaps only under certain specific cirtional activator. But possibly throwing a wrench into this cumstances, but it is not absolutely required. that PML overexpression also results in the concomitant acetylation of p53 at K320 and K382. Whether acetylaless than observed with wild-type p53. One explanation tion of p53 is required for its colocalization to or its for this is that the mutant nonacetylatable p53 is less function within NBs remains to be determined. efficient at recruiting hSir2, and hence in repressing tran-P53 Deacetylation: Shutting Down or Recruitment scription. In any event, these studies link hSir2 and its to Repression Targets? interesting connections to general cellular metabolism It is often speculated that upon moderate levels of DNA (via its NAD dependence) and life span to control of p53. damage, p53 causes cells to arrest to allow the damage How do histone deacetylase complexes silence p53-to be repaired before cells resume proliferation. If so, activated expression? This is likely to result at least in we need to consider ways that p53 might be turned off part from deacetylation of nucleosomes in the vicinity once it is no longer needed. In this regard, a speculative of the target promoter. But certainly deacetylation of function for p53 acetylation might be that it helps to other factors, including p53 itself, may contribute. Do mark a p53-activated promoter for subsequent inactivasome complexes, for example the mSin3A complex, tion. By this view, chromatin-bound p53 recruits coactiserve specifically to allow p53 to actively repress tranvators such as p300/CBP and PCAF, which function at scription of some genes, while others, such as the PID/ least in part by acetylating nucleosomal histones ( Figure  MTA2 or Sir2 (2000) revealing results that support the likely importance of identified another p53 interacting protein that they this modification. First, phosphorylation of p53, known named PID (previously identified as MTA2) that was to activate its functions, may facilitate its ability to be shown to be present in deacetylase complexes conacetylated. Sakaguchi et al.(1998) showed that N-termitaining HDAC1. Thus, p53 can enter into at least two nal peptides of p53 phosphorylated at certain key resi-HDAC1 containing complexes. When and how it funcdues were effective in blocking the ability of PCAF to tions in these complexes is unclear. Contributing to the acetylate p53. They proposed that phosphorylated p53 potential importance of deacetylases in regulating p53 is more effective in recruiting HATs than unphosphoryis the observation that rendering cells hypoxic causes lated p53 protein. of hSir2, but the degree of inhibition was substantially
